Susanne Krüger Kjær
The Danish Cancer Society Research Center
Virus, Lifestyle and Genes Unit
Strandboulevarden 49
2100 København Ø
Denmark
Rigshospitalet
Department of Gynaecology
Blegdamsvej 9
2100 København Ø
Denmark
Department of Clinical Medicine
Blegdamsvej 3B
2200 København N
Denmark
Current research
My main research focus lies within the area of clinical and molecular biological epidemiology. Most of the studies are multidisciplinary with a translational aim.
My research is largely centered around human papillomavirus (HPV), vaccination and prevention of cancers associated with HPV. We have established large population-based cohorts collecting information on lifestyle factors and different types of biological samples. We are also engaged in pharmacoepidemiological research with an initial focus on gynecological cancers such as ovarian and endometrial cancer and on skin cancer - and head/neck cancer.
My research group includes 21 researchers, who among other things, work with early diagnostics and prevention through the identification of lifestyle and socio-economic factors, genetic risk factors and other biomarkers for cancer and pre-stages with the aim of improving the prognosis. In 2019 I was appointed visiting professor at Johns Hopkins hospital, Baltimore, USA.
Main interests
- Clinical/molecular biological epidemiology
- Translational research
- Pharmacoepidemiology
- Cancer associated with HPV
- Gynecological cancer
Publications
Kahesa C, Thomsen LT, Linde DS, Mchome B, Katanga J, Swai P, Manongi R, Kjaerem M, Iftner T, Waldstrøm M, Mwaiselage J, Rasch V, Kjaer SK. Comparison of human papillomavirus-based cervical cancer screening strategies in Tanzania among women with and without HIV. Int J Cancer. 2022 Sep 12. doi: 10.1002/ijc.34283. Online ahead of print.
Baandrup L, Dehlendorff C, Kjaer SK. One-Dose Human Papillomavirus Vaccination and the Risk of Genital Warts: A Danish Nationwide Population-based Study. Clin Infect Dis. 2021 Nov 2;73(9):e3220-e3226.
Kjaer SK, Dehlendorff C, Belmonte F, Baandrup L. Real-World Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer. J Natl Cancer Inst. 2021 Oct 1;113(10):1329-1335.
Larsen HK, Hædersdal M, Thomsen LT, Hertzum-Larsen R, Lok TT, Bonde J, Sørensen SS, Hansen JM, Palefsky JM, Kjær SK. Risk of Anal High-grade Squamous Intraepithelial Lesions Among Renal Transplant Recipients Compared With Immunocompetent Controls. Clin Infect Dis. 2021 Jul 1;73(1):21-29.
Kjaer SK, Nygård M, Sundström K, Dillner J, Tryggvadottir L, Munk C, Berger S, Enerly E, Hortlund M, Ágústsson ÁI, Bjelkenkrantz K, Fridrich K, Guðmundsdóttir I, Sørbye SW, Bautista O, Group T, Luxembourg A, Marshall JB, Radley D, Yang YS, Badshah C, Saah A. Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four nordic countries. EClinicalMedicine. 2020 Jun 20;23:100401.
Publications and releases
Related employees
